Comparative efficacy and safety of phosphodiesterase-5 inhibitors with selective serotonin reuptake inhibitors in men with premature ejaculation: A systematic review and Bayesian network meta-analysis
- PMID: 30544399
- PMCID: PMC6310608
- DOI: 10.1097/MD.0000000000013342
Comparative efficacy and safety of phosphodiesterase-5 inhibitors with selective serotonin reuptake inhibitors in men with premature ejaculation: A systematic review and Bayesian network meta-analysis
Abstract
Background: We performed the network meta-analysis (NMA) and systematic review involved all evidence from relevant trials to compare the efficiency and safety of various types of selective serotonin reuptake inhibitors (SSRI) and phosphodiesterase-5 inhibitors (PDE5i) in patients with premature ejaculation (PE).
Methods: We conducted comprehensive searches of peer-reviewed and grey literature. PubMed, the Cochrane Library Central Register of Controlled Trials, Embase were searched for randomized controlled trials published up to June 1, 2017. The primary outcome was intravaginal ejaculation latency time (IVELT) and adverse effects (AEs). We performed pairwise meta-analyses by random effects model and network meta-analysis by Bayesian model. We used the GRADE framework to assess the quality of evidence contributing to each network estimate.
Results: Of 3046 titles and abstracts initially identified, 17 trials reporting 5739 participants were included. Considering IVELT in the NMA, paroxetine plus sildenafil and sildenafil alone are both superior to placebo (MD: 1.75, 95% CrI: 0.05 to 3.78; MD 1.43, 95% CrI 0.003 to 2.81). Sildenafil is superior to sertraline (MD: 1.63, 95% CrI: 0.10 to 2.79). Considering AEs, placebo demonstrated obviously lower risk comparing to paroxetine, sildenafil and paroxetine plus sildenafil (OR 0.20, 95% CI: 0.05 to 0.52; OR 0.23, 95% CI: 0.04 to 0.80; OR 0.45, 95% CI: 0.01 to 0.92). Compared with tadalafil plus paroxetine, dapoxetine showed significantly less AEs (OR 0.23, 95% CI 0.02 to 0.96).
Conclusions: Our study concluded that although paroxetine plus sildenafil and sildenafil alone both demonstrated significant IVELT benefit compared with placebo, significant increase of AEs risk was also observed. Furthermore, sildenafil alone was superior to sertraline in efficacy with comparable tolerability.
Conflict of interest statement
The authors have no conflicts of interest to disclose. Provenance and peer review Not commissioned; externally peer reviewed.
Figures
Similar articles
-
Comparative efficacy and safety of drug treatment for premature ejaculation: A systemic review and Bayesian network meta-analysis.Andrologia. 2020 Dec;52(11):e13806. doi: 10.1111/and.13806. Epub 2020 Sep 6. Andrologia. 2020. PMID: 32892379
-
Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trials.Int J Impot Res. 2018 Oct;30(5):215-223. doi: 10.1038/s41443-018-0030-x. Epub 2018 Jun 20. Int J Impot Res. 2018. PMID: 29921893
-
Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis.Eur Urol Focus. 2017 Feb;3(1):119-129. doi: 10.1016/j.euf.2016.02.001. Epub 2016 Feb 19. Eur Urol Focus. 2017. PMID: 28720356 Free PMC article.
-
Efficacy of Phosphodiesterase-5 Inhibitor in Men With Premature Ejaculation: A New Systematic Review and Meta-analysis.Urology. 2015 Nov;86(5):947-54. doi: 10.1016/j.urology.2015.06.051. Epub 2015 Aug 14. Urology. 2015. PMID: 26278825 Review.
-
Interventions to treat premature ejaculation: a systematic review short report.Health Technol Assess. 2015 Mar;19(21):1-180, v-vi. doi: 10.3310/hta19210. Health Technol Assess. 2015. PMID: 25768099 Free PMC article. Review.
Cited by
-
Premature ejaculation - current concepts in the management: A narrative review.Int J Reprod Biomed. 2021 Jan 25;19(1):5-22. doi: 10.18502/ijrm.v19i1.8176. eCollection 2021 Jan. Int J Reprod Biomed. 2021. PMID: 33553999 Free PMC article. Review.
-
Carbapenems vs tigecycline for the treatment of complicated intra-abdominal infections: A Bayesian network meta-analysis of randomized clinical trials.Medicine (Baltimore). 2019 Oct;98(40):e17436. doi: 10.1097/MD.0000000000017436. Medicine (Baltimore). 2019. PMID: 31577763 Free PMC article.
References
-
- Porst H, Montorsi F, Rosen RC, et al. The premature ejaculation prevalence and attitudes (pepa) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol 2007;51:816–24. - PubMed
-
- Serefoglu EC, McMahon CG, Waldinger MD, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. Sex Med 2014;2:41–59. DOI:10.1002/sm2.27.PMID:25356301. - PMC - PubMed
-
- Washington DC. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision. (DSM-IVTR). American Psychiatric Association, 2000:554
-
- Symonds T, Roblin D, Hart K, et al. How does premature ejaculation impact a man's life? J Sex Marital Ther 2003;29:361–70. - PubMed
-
- Rowland D, Perelman M, Althof S, et al. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med 2004;1:225–32. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources